Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study

NCT06872632 · tracked via the Priya Life Science Italy tracker
Sponsor
Società Italiana di Medicina Interna
Phase
Observational
Started
2024-06-24
Last updated
2025-03-12

Condition(s) studied

Complexity and Multiple Illnesses of Adult Hospitalized Internal Medicine Patient

Study summary

The goal of this observational study is to evaluate the association between complexity and multiple illnesses of adult hospitalized internal medicine patient and mortality. The observational study will also evaluate the association between pre-existing factors at hospitalization and clinical outcomes such as mortality, length of hospital stay, intensity of care (transfer to units with higher clinical intensity), complications and rehospitalization.

For data collection, four index weeks will be identified during the year in which the participating Centers will have to sequentially enroll all the participants who will be admitted to the Internal Medicine units, until reaching, for each index week, 10 participants for each of the Participating Centers.

Each enrolled participant will undergo a 12-month follow-up. The study foresees the enrollment of 2326 participants.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients of legal age (age \>= 18 years). 2. Informed consent according to Italian law. Exclusion Criteria: * No specific exclusion criteria were identified.

Primary outcome measure(s)

  • to evaluate the correlation between clinical complexity/multimorbidity of the hospitalized internal medicine patient, defined by the Cumulative Illness Rating Scale (CIRS), and mortality. — 12 months
    to evaluate the correlation between clinical complexity/multimorbidity of the hospitalized internal medicine patient, defined by the Cumulative Illness Rating Scale (CIRS), and mortality. Cumulative Illness Rating Scale: severity index (minimum value is 1, maximum value is 5), comorbidity index (minimum value is 0, maximum value is 13). Higher scores mean worse outcome.

Trial sites (12)

FacilityCityRegionStatus
AOU Policlinico di Bari- Unità Operativa di Medicina Interna "Guido Baccelli Bari Italy Recruiting
Azienda Ospedaliero Universitaria di Bologna Policlinico S. Orsola - Malpighi- UO Medicina interna, malattie epatobiliari e immunoallergologiche Bologna Italy Recruiting
ASST degli Spedali Civili di Brescia- Medicina Generale 2 Brescia Italy Recruiting
Azienda Ospedaliero-Universitaria S. Anna di Ferrara- Clinica Medica Ferrara Italy Recruiting
Ospedale Santa Maria Annunziata, Bagno a Ripoli, Firenze- Medicina 1 Florence Italy Recruiting
AOU G. Martino- UOC Medicina Interna Messina Italy Recruiting
ASST Fatebenefratelli Sacco, Ospedale Luigi Sacco- Struttura Complessa di Medicina Interna Milan Italy Recruiting
AOU Modena - Policlinico di Modena - S.C. Medicina Interna Modena Italy Recruiting
Azienda Ospedaliera Universitaria Federico II, Napoli- UOC Medicina Interna ad indirizzo metabolico e riabilitativo Naples Italy Recruiting
Ospedale Maggiore della Carità di Novara- SCDU Medicina Interna 1, AOU Maggiore della Carità Novara Italy Recruiting
Policlinico Universitario Campus Bio-Medico di Roma- UOC Medicina Interna Roma Italy Recruiting
Azienda Ospedaliero-Universitaria Sant'Andrea- UOC Medicina Interna Roma Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06872632 on ClinicalTrials.gov ↗ ← All trials in Italy